Cti Biopharma reported $131K in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Baxter International BAX:US USD 683M 0
Cti Biopharma CTIC:US USD 131K 4K
Cytori Therapeutics CYTX:US USD 34K 2K
Geron GERN:US USD 390K 8K
Mirati Therapeutics MRTX:US USD 58K 0
Northwest Biotherapeutics NWBO:US USD 1.05M 17K
Novartis NOVN:VX USD 890M 0
Novartis NVS:US USD 890M 0
Seattle Genetics SGEN:US USD 187K 2K
Teva Pharmaceutical Industries TEVA:US USD 57M 0